Beta defensin 2 - Planton GmbHAlternative Names: Antimicrobial peptides - PLANTON; Recombinant-human-beta-defensin-2; rHuB-D2
Latest Information Update: 16 Jul 2016
At a glance
- Originator Planton
- Class Antibacterials
- Mechanism of Action Beta defensin modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Atopic dermatitis; Bacterial infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Bacterial-infections in Australia (Topical, Cream)
- 16 Jul 2016 No recent reports of development identified for phase-I development in Atopic-dermatitis in Australia (Topical, Cream)